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Abstract: Wine consumption has been popular worldwide for many centuries. Based on in vitro
and in vivo studies, a certain amount of everyday wine consumption may prevent various chronic
diseases. This is due, in part, to the presence and amount of important antioxidants in red wine, and,
therefore, research has focused on them. Wine polyphenols, especially resveratrol, anthocyanins,
and catechins, are the most effective wine antioxidants. Resveratrol is active in the prevention
of cardiovascular diseases by neutralizing free oxygen radicals and reactive nitrogenous radicals;
it penetrates the blood-brain barrier and, thus, protects the brain and nerve cells. It also reduces
platelet aggregation and so counteracts the formation of blood clots or thrombi. The main aim of this
review is to summarize the current findings about the positive influence of wine consumption on
human organ function, chronic diseases, and the reduction of damage to the cardiovascular system.
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1. Introduction
Red wine is popular worldwide and is beneficial due to the presence and amount of its compounds.
The tradition of winemaking and wine consumption has been known for many centuries. The ancient
Romans knew the health benefits of wine and popularized it [1]. The main product of grapes is wine.
Wine is composed mainly of water, carbohydrates, organic acids, minerals, alcohol, polyphenols,
and aromatics [2]. Wine contains substances that have a significant effect on cardiovascular diseases
and on some chronic diseases [3].
Antioxidants are necessary for good cardiovascular function. They can be found in many plants,
such as fruits (and their derivative products i.e., jams, juices, wine, etc.) and vegetables. Their presence
in food and drink reduces the risk of cardiovascular diseases, some cancers, and diabetes [3,4].
Red wine consumption has been shown to decrease the blood pressure of hypertensive patients [5].
One of the most notable classes of wine compounds is polyphenols. The polyphenol composition
and exact content are dependent on factors, such as the grape variety. White wines usually contain less
polyphenols than red ones. The total polyphenol content in white wine is in terms of hundreds of mg
GAE.L−1 (gallic acid equivalents) [6]. Red wine total polyphenol content is in terms of thousands of
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mg GAE.L−1. According to some studies [4], red wine polyphenols reduce the risk of cardiovascular
diseases and have a positive impact on individual human organs.
The most important polyphenols in red wine are resveratrol, anthocyanins, catechins, and tannins
(proanthocyanidins and ellagitannins) [7]. Resveratrol has a biological activity, plays an important role
in cardiovascular diseases, and is present in a restricted number of foods, such as red wine and wine
grapes. Its cardioprotective effects include improving endothelial function and glucose metabolism,
reducing inflammation, and regulating blood lipids. Other wine polyphenols are an integral part of
these actions and contribute positively to the beneficial effects of wine [5].
The aim of this overview is to summarize the various wine components, their antioxidant
properties, significant polyphenols and their health benefits in relation to the cardiovascular system,
and the effect on individual organs.
2. Red Wine and Its Antioxidants
The antioxidants found in many red purple berry fruits (grapes of red wine, Aronia, etc.) are
categorized as individual polyphenols. The activity of berry fruit polyphenols in reducing the risk
of cardiovascular diseases has been studied by Kim et al. [8]. The results showed the beneficial
effects of polyphenols on heart function, reduction of cardiovascular diseases, arteriosclerosis and
heart attacks, and reduced risk of hypertension and diabetes. Schini-Kerth et al. [9] examined the
positive effect of regular consumption of food and drinks rich in polyphenols, such as red wine, tea,
chocolate, and vegetables, on endothelial cells. Qureshi et al. [10] conducted a study about the foods
and beverages contributing to antioxidant intake in a group of women aged 50 to 69 years. Women
with a higher antioxidant intake (major contributors were coffee, tea, red wine, blueberries, walnuts,
oranges, cinnamon, and broccoli) were at a lower risk for cardiovascular diseases, heart arrhythmia,
hypertension, and diabetes. Women with regular red wine consumption were found to have the
lowest risk.
One of the important and studied polyphenols of wine is resveratrol. Resveratrol, lipophilic
3,4′,5-trihydroxystilbene, found in grapes and red wines, exhibits a variety of pharmacological
properties. The amount of resveratrol differs depending on the variety, geographical location, time of
harvest, maturity, and health of the grapes [5].
Resveratrol, in some research, has shown cardioprotective benefits in humans, but Tome-Carneiro et al. [11]
suggest that resveratrol’s positive effects are overestimated because of its low concentration in foods
and low bioavailability in humans. These ideas are both supported and disproved by many clinical
studies. In addition, long-term excessive intake of resveratrol decreases the activity of some isoenzymes,
which may be damaging for human health [12].
Montsko et al. [13] tested a wide range of wines to find out which type of wine is richest in
polyphenols. The richest in trans-resveratrol were Pinot noir and St. Laurent red wines. For moderate
daily consumption, the daily dosage of these two types of red wine that reduced the risk of cancer
and cardiovascular diseases was 0.3 L for men and around 0.2 L for women. Pandey and Rizvi [14]
reviewed the cardioprotective effects of resveratrol on myocardial cells against ischemia. Its role as a
sirtuin activator, which detoxifies the body, was studied on reactive oxygen species (ROS). The results
showed that resveratrol increased the cardioprotective effect against oxidative damage.
Due to its important bioactivities and the high popularity of red wine, resveratrol has spread
amongst the public in the form of food supplements. Chinese laboratories studied the role of resveratrol
in protecting endothelial function. The study reported a resveratrol dosage that protects blood
vessels in vivo and in vitro. Nowadays, it is used as a food supplement for diabetic angiopathy
prevention [15,16].
Das et al. [17] investigated the effects of resveratrol on cellular signalling networks that involved
protein kinase C (PKC alpha) as a possible mechanism by which resveratrol affects many disease
states. Resveratrol and its derivatives reduced PKC alpha activity. This strategy can be used to
regulate diseases affected by protein kinase C. The main goal of the Mannari et al. [18] article was to
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investigate the cardio- and nephroprotective effects of resveratrol by modulating the nitric oxide (NO)
system. Their research showed that one of the main actions of NO modulation is sirtuin regulation,
especially by the SIRT1 protein. Resveratrol is a sirtuin activator. Final results showed that incubation
of tubular cells with resveratrol increased SIRT1 expression as compared to the control group.
Ghanim et al. [19] studied the effect of resveratrol using a plant extract on heart and vascular
diseases. The group with resveratrol intake on an empty stomach had no change in the concentrations
of LDL (low density lipoprotein), HDL (high density lipoprotein), cholesterol, triglycerides, and leptin
compared to the control group. This study pointed out the importance of an exact dose to ensure
a definitive positive effect. If a consistent effective dosage was not used, a loss of antioxidant
ability and nonspecific reactions with proteins occurred. Food supplements with resveratrol were
mentioned in the review of Rahman et al. [20]. A wide range of beneficial effects of resveratrol on
human health was described. The most significant results were reductions of cardiovascular diseases
(hypertension, hypertrophy, coronary artery disease, and arteriosclerosis) in a group of people with
regular moderate wine intake. The mental health of wine consumers was also better than the mental
health of non-drinkers.
Romain et al. [21] investigated the effect of a grapevine shoot extract (Vineatrol 30) with a high
concentration of resveratrol on the cardiovascular and hepatic systems in hamsters with induced
arteriosclerosis. The extract increased antioxidant and anti-inflammatory activity and prevented aortic
lipid deposition, which protects against infarction and other heart diseases. Mokni et al. [22] also
studied the cardioprotective effects of resveratrol in rats. Data showed that resveratrol improved
recovery of post-ischemic ventricular functions compared to control animals. Resveratrol also
improved myocardial lipoperoxidation, myocardial free iron, and antioxidant enzyme activities.
The effect of certain doses of resveratrol on blood pressure, oxidative stress, and reactive oxygen
species has been studied [19,23–29]. A summary of these studies is shown in Table 1.
Table 1. Summary of some studies with resveratrol dosage (mg) and its effect.
Participants Condition ResveratrolDose (mg) Duration Downregulation Effect Ref.
20 (undifferentiated sex) healthy 40 6 weeks Reactive oxygen species (ROS) [19]
10 (4 men, 6 women) healthy 100 1 week ROS, Toll-like receptor 4 [23]
19 (men) diabetic 10 1 month ROS [24]
11 (men) obese 300 1 month ROS, glucose, insulin [25]
50 (undifferentiated sex) smokers 500 1 month ROS, C-reactive protein [26]
62 (undifferentiated sex) healthy 250 3 month Systolic BP, cholesterol [27]
10 (men) obese 150 1 month Postprandial glucagon resp. [28]
24 (undifferentiated sex) diabetic 100 2 month Reduction of foot ulcer size [29]
Dos Santos et al. [30] studied resveratrol to evaluate its effects on calorimetric parameters (oxygen
consumption, carbon dioxide production, respiratory quotient), antioxidants in the myocardium,
and the energy metabolism of diabetic rats. The results showed that the cardioprotective effect of
resveratrol may be mediated through its ability to normalize free fatty acid oxidation, enhance glucose
utilization, and control the level of oxidative stress under diabetic conditions.
Semba et al. [31] demonstrated the possible effects of resveratrol on study participants, which
included both men and women who were 65 years or older and from the Chianti area. Of the 639
participants, 174 developed cardiovascular disease and this occurrence was higher with a decreasing
concentration of resveratrol. Urinary resveratrol metabolites demonstrated no substantial influence
on longevity and lowering the risk of cardiovascular diseases when resveratrol intake was dietary.
Menet et al. [32] showed a positive absorption of resveratrol and its metabolites in the plasma of
non-human primates (Microcebus murinus), and implied a similarity with humans.
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Another antioxidant present in red wine, as well as in tea, various fruits, vegetables, and seeds,
is flavonoid rhamnetin. Park et al. [33] studied the effect of rhamnetin on cardiac myocytes under
oxidative stress and showed the protective effects of rhamnetin against apoptosis in cardiomyoblasts
by inhibiting free oxygen radicals.
Quintieri et al. [34] investigated malvidin (malvidin-3-0-glucoside or oenin), the most common
wine anthocyanin, on cardiovascular function. The study results confirm the significant positive
effects of malvidin, the most common polyphenol in red grape extracts, on cardioactivity by eliciting
cardioprotection against ischemia/reperfusion damage. This major red wine anthocyanin, malvidin,
was also closely studied by Bognar et al. [35] using cell exposure to malvidin. Malvidin reduced
the course of chronic inflammation, inhibited phosphorylation activation, nuclear translocation,
mitochondrial destabilization, prevented the formation of oxygen free radicals, and increased
antioxidant activity.
An important polyphenol class in wine, from the grape skin, seeds, and stems, is the tannins.
The main classes are condensed tannins (proanthocyanidins), created by the polymerization of
flavan-3-ol monomers, and hydrolysable tannins (from oak barrels). Tannin structures are shown in
Figure 1.
Oenological processing can affect the final concentrations of these compounds. They are often
present in red wine in levels of 300 mg/L [36]. Corder et al. [37] identified red wine procyanidins as
the principal vasoactive polyphenols. Traditional wine production methods confirm that procyanidins
are efficiently extracted during vinification. The oak barrels are used in viticulture to ripen red wine.
Panchal et al. [38] studied the effects of a mixture of ellagitannins from oak bark (Quercus petraea L.)
on cardiovascular, metabolic, and hepatic changes in spontaneously hypertensive rats and rats on a
high-fat diet. The tannin extracts improved cardiovascular, metabolic, and hepatic function, which
shows that ellagitannins from oak bark can enhance the positive effects of red wine.
Rossi et al. [39] studied the relationship of dietary antioxidants from beverages, such as wine,
with acute myocardial infarction and its prevention. They found that the amount of antioxidants
was inversely related to the risk of acute myocardial infarction. The authors encouraged moderate
consumption of wine and high consumption of fruit and vegetables.
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3. Alcohol and Wine Consumption and Their Impact on Human Health
The relationship between alcohol and wine consumption and human health effects has been
studied by many researchers [40–52].
Elmadhun et al. [40] carried out an experimental study on pigs. Their findings suggested
that, in moderate doses, ethanol directly promotes new vessel growth in nonischemic myocardium.
Platisa et al. [41] have investigated the protective effect of a moderate consumption of red wine on
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the cardiovascular system. In separate experiments, volunteers drank 0.2 L of red wine and 0.2 L of a
control alcohol drink (13.5% alcohol). The immediate effect of both drinks was equal and they increased
systolic and diastolic blood pressure. However, after ten minutes, all measured data returned to normal.
The prolonged effect of wine and the control drink was different as wine decreased blood pressure and
reduced the complexity of the heart-interbeat interval and ventricular repolarization interval.
Matsumoto et al. [42] studied the positive effects of moderate alcohol intake on cardiovascular
diseases in adult women and men. The results showed that consumption of 0.15 L of wine or
0.33 L of beer or 0.03 L of liquor lowered the risk of ischemic myocardium, cardiomyopathy, and
overall mortality.
The study of Toth et al. [43] indicates the importance of a definitive alcohol dose for a positive
effect. Using 39 healthy, non-smoking volunteers aged 18 to 40 years (one group drank water,
second group drank 0.2 L of red wine each day for three weeks), they demonstrated the favourable
hemorheological effects of red wine. After three weeks, red blood cell aggregation decreased in
the group drinking the red wine. Red wine consumption increased red blood cell deformability at
high shear stress. These results show that moderate red wine consumption has beneficial effects
on haematological parameters, which are generators of cardiovascular diseases, especially coronary
artery disease. Elmadhun et al. [44] studied the effects of low to moderate alcohol intake on the
risk of developing cardiovascular diseases. They developed a clinically relevant animal model (pigs)
for chronic myocardial ischemia to investigate the effects of moderate alcohol consumption on the
myocardium. The results showed that alcohol consumption regulates apoptosis and promotes cell
survival in ischemic and non-ischemic myocardium. Wine was recommended for its optimal amount
of ethanol and other substances with cardioprotective effects. A dietary study of 108 patients with
carotid atherosclerosis (65% on statin therapy) who did or did not drink red wine daily (0.1 L women,
or 0.2 L men) was performed by Droste et al. [45]. The modified diet and physical exercise, as well as a
daily glass of red wine, independently improved the LDL/HDL ratio in patients with arteriosclerosis,
even for those on statin therapy.
Chu et al. [46] investigated the effects of two alcoholic beverages, red wine (Pinot noir) and vodka,
on cardiovascular function in hypercholesterolemic swine. The goal was to improve a perfusion
of ischemic myocardium. Daily intake of 0.375 L of wine or 0.1 L of vodka reduced the risk of
cardiovascular diseases compared to normal adult swine.
The objective of the study of Yoo et al. [47] was to examine the health perceptions of red and
white wine drinkers from Australia and Korea. Consumers prefer red wine, consuming this with an
awareness of the health benefits and protection against myocardial infarction, cardiovascular diseases,
and hypertension. The cardioprotective effect of moderate alcohol consumption was examined by
Djoussé et al. [48]. The participants of this study were women, including both alcohol consumers
and non-drinkers. The participants’ cardiovascular mortality and alcohol consumption rates were
followed for 12 years. As compared with abstainers, alcohol drinkers, with an intake of 5 to 15 g per
day, were associated with a 26% lower risk of cardiovascular disease, 35% lower risk of total mortality,
and 51% lower risk of cardiovascular disease mortality, if the alcohol consumption was mostly red
wine. Another study investigated the effects of regular alcohol consumption on the incidence of
cardiovascular diseases and all-cause mortality. They studied the aspects of the overall alcohol-drinking
pattern, all-cause mortality, and the risk of cancer and cardiovascular disease. The participants were
more than 20,000 Mediterranean university graduates, surveyed every two years. The results showed
a significantly lower incidence of death and cardiovascular diseases among wine drinkers than
among beer or other alcohol drinkers. This outcome was associated with alcohol intake volume (men
20 g/day, women 10 g/day) in combination with polyphenol intake and the healthier lifestyle of
wine-drinkers [49].
O′Keefe et al. [50] wanted to clarify the healthy intake of alcohol as heavy alcohol use is
an important factor in the occurrence of reversible hypertension, nonischemic cardiomyopathy,
atrial fibrillation, and risk of ischemic stroke. This study had 27,000 participants, including both
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men and women. They specified that regular low- to moderate-dose alcohol intake (0.1 L of wine per
day for women and up to 0.2 L of wine per day for men) is associated with a decrease in the risk of
adverse cardiovascular outcomes. The most suitable alcohol source seemed to be red wine.
During few last decades, the French paradox has been mentioned quite often. It means that
French people have a relatively low incidence of coronary heart disease despite a diet that includes a
high amount of saturated fat. Yamagata et al. [51] studied the preventive effects of polyphenols on
cardiovascular diseases and their positive effects on the function of the endothelial cells. Observations
of 129,000 adults showed a decreased risk of mortality from cardiovascular diseases in wine consumers
compared to other alcohol drinkers. Sinkiewicz et al. [52] also reviewed the reason for the French
paradox. Here, lower coronary artery disease occurrence was associated with consumption of wine
rather than beer and other alcoholic beverages. People drinking three glasses of red wine every day
had the lowest risk of cardiac diseases and mortality. Sufficient daily wine intake also decreased high
blood pressure and the risk of myocardial infarction in men aged 65 years and older.
The Hispanic paradox is also being examined in the literature, as well as the French paradox.
This anomaly was reviewed by Medina-Inojosa et al. [53]. Daily moderate wine consumption was
considered the main reason for decreased cardiovascular diseases. A couple of Hispanic groups living
in Europe, USA, and South America were observed and data about their lifestyle, foods, and health
condition were collected. The results showed a lower occurrence of cardiovascular diseases compared
to other non-Hispanic inhabitants.
Vilahur and Badimon [54] reviewed the cardioprotective effects of the Mediterranean diet on
coronary artery disease and atherosclerosis. Their review confirmed that long-term, daily red wine
consumption of 0.15 L for women and 0.45 L for men reduced inflammation and atherosclerosis, and
improved lipid metabolism, antioxidant state, and endothelial function. Cioni et al. [55] compared
relationships between life style, especially eating habits, and endothelial function and coronary artery
disease. The study population was composed of 95 clinically stable females (47.9%) and males
(42.1%) in primary prevention for cardiovascular disease. All participants underwent a medical
questionnaire, clinical examination, and peripheral-arterial tonometry. The reactive hyperaemia index
values were higher and the risk of endothelial dysfunction and cardiovascular diseases decreased
for participants on the Mediterranean diet with moderate wine consumption. Giacosa et al. [56]
describes a Mediterranean diet as being effective in cardiovascular prevention and mortality. This study
showed that the Mediterranean diet is beneficial to health even among populations outside the
Mediterranean basin.
Tognon et al. [57] studied Dutch inhabitants with different eating habits and the related risk of
stroke, coronary heart disease, and cardiovascular mortality. The study had 1849 men and women
as participants. The group with Mediterranean dietary eating habits was associated with a lower
risk of coronary heart disease and cardiovascular mortality, but not of stroke. The group consuming
wine for its alcohol intake was inversely associated with total mortality and with cardiovascular and
myocardial infarction incidence and mortality. Stricker et al. [58] explored differences in 40,011 men
and women in one group with high intakes of fish, high-fibre products, vegetables, and wine, and a
second group, with a Western lifestyle (high consumption of French fries, fast food, low-fibre products,
and other alcoholic drinks), for the occurrence of coronary heart disease and stroke. After 13 years of
follow-up, 1843 coronary heart disease and 588 stroke cases were documented. The first group was
associated with a reduced risk of coronary heart disease and stroke, and the second Western group
was not related to any outcome.
Table 2 summarizes the benefits of wine or alcohol and their effects on human health.
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Table 2. Summary of recommended doses of wine or other alcohol and their effects on human health.
Recommendation Kind of Alcohol Effect Refs.
0.2 L Red wine Increased systolic and diastolic bloodpressure, hypertension [41,47]
0.15 L of wine or 0.33 L of beer or 0.03 L of liquor
Lowered the risk of ischemic
myocardium, cardiomyopathy and
overall mortality
[42]
0.2 L Red wine Beneficial effects on coronary arterydisease, cardioprotective effect [43,48]
0.1 L women or 0.2 L men of red wine Improved independently the LDL/HDLratio in patients with arteriosclerosis [45,50]
0.375 L of wine or 0.1 L of vodka Reduce the risk of cardiovascular diseases [46]
0.15 L for women, 0.45 L for men of red wine
Reduced inflammation, atherosclerosis,
improved lipid metabolism, antioxidant
state, and endothelial function
[54]
4. Red Wine Effects on Humans Organs
The first organ that encounters the wine is the oral cavity followed by the esophagus.
Phytochemicals contained in wine, such as lignans, quercetin, and resveratrol, have estrogenic
properties. Peterson et al. [59] reviewed several studies about lignans and confirmed a positive effect
on cardiovascular diseases. Animal research suggests that they synergistically reduce the incidence
of cancer. The protective effects of lignans on the development of human esophageal cancer have
shown that these three phytochemicals can synergistically reduce esophageal cancer [60]. A serious
disease of the esophagus is Barrett′s esophagus, a premalignant condition. Barrett′s esophagus is a
complication of gastroesophageal reflux disease [61]. It was supposed that alcohol may increase the
risk of Barrett′s esophagus through direct contact with esophageal mucosa. However, findings for
this association are inconsistent. Inverse associations were observed for wine and beer consumption,
and liquor consumption doubled the risk, but they were not statistically significant. Moreover, wine
consumption has been associated with a moderately reduced risk of Barrett′s esophagus [62,63].
The stomach follows the esophagus. The gastric mucosa can be colonized by Heliobacter pylori,
a gram-negative bacterium. Alcoholic beverages, especially red wine, probably have antibacterial
activity against Helicobacter pylori and a protective effect against the ulcerogenic effect of ethanol on
gastric mucosa. Flavonoids are responsible for these beneficial effects [64]. The consumption of 0.1 L of
red wine has the potential to reduce the risk of gastric cancer. A statistical analysis by Barstad et al. [65]
was carried out using a linear trend test. At the end of the study, it was suggested that daily intake of
wine can prevent the development of stomach cancer.
The intestines are important organs in the gastrointestinal tract of the digestive system, and their
cancers are the third most common cancer in men and women, accounting for 9% of total cancer
deaths [66]. Polyphenols contained in wine can prevent or delay the progression of inflammatory
bowel disease of the colon and small intestine. Wine polyphenols act as free radical scavengers and
modulators of specific genes and can act as probiotics and antimicrobials. Therefore, they could be used
for the prevention or treatment of inflammatory intestinal diseases [67,68]. These theses were verified
by an experiment on intestinal tumor progression in rats by administering 0.2 mg of trans-resveratrol
in their drinking water over 100 days. A significant, visible decrease in the tumors was observed after
a daily dosing of 8 mg of trans-resveratrol. The results showed that this polyphenol can suppress the
progression of the malignant phase of intestinal cancer [69].
The next organ influenced by wine consumption is the liver. Hepatocellular carcinoma, also called
primary cancer, is the sixth most common cancer in the world. Bishayee et al. [70], in his review,
found resveratrol prevents and controls hepatocellular carcinoma. Resveratrol inhibited carcinogenesis,
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with a pleiotropic effect. Carbo et al. [71] investigated the antitumor potential of resveratrol in animal
models of liver cancer. They showed that the use of resveratrol has not only a chemopreventive effect,
but it is also effective as a chemotherapeutic agent. Following administration of resveratrol to rats
inoculated with rapidly growing hepatoma cells, resveratrol caused a significant reduction in the
tumor cell number. Oral administration of 20 mg of resveratrol daily for six weeks can significantly
prevent the loss of liver weight and inhibit serum alanine aminotransferase, aspartate aminotransferase,
alkaline phosphatase, and bilirubin levels. Resveratrol had in vivo hepatoprotective effects against
antifibrogenic dimethylnitrosamine-induced liver injury, suggesting that it may be useful in preventing
the development of hepatic fibrosis [72].
Pancreatic cancer has few early symptoms and is usually diagnosed in the later stages. Alcohol has
been promoted as a supporter of pancreatic cancer. Recent epidemiological studies show contradictory
results regarding alcohol intake and pancreatic cancer. Resveratrol binds directly to leukotriene
A(4) hydrolase in vitro and in cells, and suppresses the proliferation of and anchorage-independent
pancreatic cancer growth by inhibiting leukotriene B(4) production and leukotriene B(4) receptor
1 expression. Resveratrol has a relatively stronger inhibitory effect than bestatin, an inhibitor of
leukotriene A(4) hydrolase activity. It is important that resveratrol inhibits tumor formation in the
xenograft model of human pancreatic cancer cells [73].
Table 3 summarizes the information on human organs and the effects of various components of
wine on various diseases.
Table 3. Overview of human organs, their diseases, and the effects of wine components.
Organ Disease Substance and Dosage Effect Refs.
Esophagus CancerBarrett’s esophagus
Phytochemicals (lignans,
quercetin, resveratrol) in wine
Synergistically reduces esophageal
cancer, moderately reduced risk of
Barrett’s esophagus
[59–63]
Stomach Helicobacter pyloriCancer
Flavonoids, ethanol, alcoholic
beverages, especially red wine
0.1 L/day of red wine
Antibacterial activity, protective effect
against the ulcerogenic effect of ethanol
on gastric mucosa
[64,65]
Intestines Cancer IBD
Wine polyphenols, probiotics,
and antimicrobials
8 mg of trans-resveratrol
Reduced progression of malignant
phase of cancer, prevent or delay
progression of inflammatory bowel
disease of colon and small intestine
[66–69]
Liver Hepatocellularcarcinoma
Resveratrol
20 mg resveratrol daily
Inhibited carcinogenesis with a
pleiotropic effect, chemopreventive
effect, in vivo hepatoprotective effects
[70–72]
Pancreas Cancer Resveratrol
Suppresses proliferation of
anchorage-independent growth by
inhibiting leukotriene B(4) production,
leukotriene B(4) receptor 1 expression
[73]
5. Biological Mechanisms of Human Body Influenced by Wine Consumption
5.1. Lipid Metabolism
Da Luz et al. [74] investigated the health benefits of moderate red wine consumption, with a
focus on coronary vasculature. The study included 101 alcohol drinkers aged around 60 years and
104 abstainers. The results showed that regular red wine drinkers have similar coronary plaque and
endothelial function, higher HDL cholesterol level and lower occurrence of coronary lesions compared
to abstainers.
Janega et al. [75] analysed the effect of alcohol-free Alibernet red wine extract on nitric oxide
synthase activity and pro-inflammatory markers that affect genes significant for immunity and
inflammation in rats. Alibernet red wine extract treatment did not affect total and endothelial NO
synthase activity, but it was able to decrease pro-inflammatory marker activity and inducible NO
synthase expression in both the left ventricle and aorta. Calorie restriction in combination with an
exact resveratrol dosage was associated with cardioprotective function against doxorubicin-induced
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damage in 26-month-old rats. This was also observed by Dutta et al. [76] in the hearts of 26-month-old
rats. They studied resveratrol as a possible autophagy inductor. Autophagy is a cellular self-digestion
process whereby cells degrade dysfunctional proteins and organelles. Other beneficial results were the
vasodilatory, anti-inflammatory and antioxidative effects.
Lee et al. [77] checked the effects of non-alcoholic red wine concentrate on cholesterol level and
related occurrence of cardiovascular diseases using in vitro and in vivo models. Regular moderate
consumption reduced the risk of cardiovascular diseases and increased antioxidant activity. The study
demonstrated the reduction of plasma cholesterol, LDL cholesterol and total cholesterol in an animal
model, as well as a decrease in intracellular total cholesterol and triglyceride in vitro. HDL cholesterol
remained unchanged.
Karadeniz et al. [78] concentrated their attention on possible solutions to lower high obesity and
heart diseases. A direct relationship between obesity, oxidative stress markers and susceptibility of
LDL to oxidation was demonstrated. As expected the levels of total cholesterol, triglycerides and
LDL cholesterol were higher in obese patients, but following wine consumption, antioxidant and
paraoxonase activities increased, which led to a decreased LDL cholesterol level.
Xiang et al. [79] conducted a study on the effect of red wine consumption and its beneficial effects
on reducing the risk of heart diseases and lifespan extension attributed to its high antioxidant content.
The aim of the article was to study relative contribution of wine polyphenols on health. They found
that anti-radical activity correlates with total amount of polyphenols.
The paragraph dealing with lipid metabolism is summarized in the Table 4.
Table 4. Randomized controlled trial of lipid metabolism.
Study Model Outcome Study Effect Refs.
In vivo Levels of total cholesterol,
triglycerides and LDL
cholesterol
Effects of non-alcoholic red wine
concentrate on cholesterol level
and related occurrence of
cardiovascular diseases
Antioxidant and paraoxonase
activities increased, decrease in
intracellular total cholesterol and
triglyceride
[77,78]
In vitro
Sewer rats Autophagy Resveratrol as a possibleautophagy inductor
Vasodilatory, anti-inflammatory and
antioxidative effects [76]
Rats Endothelial NO
Effect of alcohol-free Alibernet
red wine extract on NO
synthase activity and
pro-inflammatory markers
Decrease pro-inflammatory marker
activity and inducible NO synthase
expression in both the left ventricle
and aorta
[75]
Humans LDL, HDL, coronary plaqueand endothelial function
Health benefits of moderate red
wine consumption
Higher HDL cholesterol level and
lower occurrence of coronary lesions
compared to abstainers
[74]
5.2. Diabetes Mellitus
Da Luz et al. [74] investigated the health benefits of moderate red wine consumption, with a focus
on glucose levels and diabetes. The study included 101 alcohol drinkers aged around 60 years and 104
abstainers. The results showed that regular red wine drinkers have lower glucose levels and a lower
occurrence of diabetes compared to abstainers.
Bresciani et al. [80] conducted a study with 73 male rats of 13-weeks old. The groups with no
resveratrol intake and the lowest dosage had the highest glucose level increases. The group with the
highest resveratrol dosage had decreased glucose levels after three weeks. The highest dosage intake
led to the recovery of hemodynamic performance. The lower dosage was less effective.
Chiva-Blanch et al. [81] studied the benefits of moderate consumption of alcohol (red wine,
dealcoholized red wine, and gin) on glucose metabolism. Moderate alcohol intake, either red wine
(30 g of alcohol per day), the same amount of dealcoholized red wine, and gin (same amount of
alcohol), consumed for four week periods demonstrated that red wine and dealcoholized red wine
consumption decreased plasma insulin and the homeostasis model assessment of insulin resistance,
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therefore, it was concluded that red wine is protective against type 2 diabetes in association with an
improved insulin sensitivity.
Blomster et al. [82] had similar results in patients with type 2 diabetes. The prevalence of type
2 diabetes is increasing and is influenced by lifestyle factors, such as high-calorie diet consumption,
sedentary behaviour, and the resultant increase in excess weight. The aim of this study was to establish
the effects of moderate alcohol consumption on cardiovascular disease in diabetic patients. Compared
with patients who reported no alcohol consumption, those who reported moderate consumption had
fewer cardiovascular events and a lower all-cause mortality. The benefits were particularly evident in
participants who predominantly drank wine.
This section dealing with diabetes mellitus is summarized in the Table 5.
Table 5. Randomized controlled trial of diabetes mellitus.
Study Model Outcome Study Effect Ref.
Drinkers vs. Glucose level and
diabetes
Health benefits of moderate
red wine consumption
Drinkers have lower glucose
levels and a lower occurrence of
diabetes compared to abstainers
[74]
Abstainer
Rats Glucose level Dosage of resveratrol Highest resveratrol dosagedecreased glucose levels [80]
Men Glucosemetabolism
Benefits of moderate
consumption of alcohol (red
wine, dealcoholized red
wine, and gin)
Decreased plasma insulin and the
homeostasis model assessment of
insulin resistance
[81]
Type 2
diabetics CVD
Establish the effects of
moderate alcohol
consumption on
cardiovascular disease in
diabetic patients
Moderate consumption had fewer
cardiovascular events and lower
all-cause mortality
[82]
5.3. Oxidative Stress
Oxidative stress is an important component of various diseases related to the production of
reactive oxygen species, cardiovascular risk factors, and cellular dysfunction.
Chiva-Blanch et al. [83] evaluated the effects of alcoholic and non-alcoholic red wine and gin
consumption in 67 men with high cardiovascular risk. They randomized them into groups with a
dose of either red wine or gin, both with the same alcohol content. Dealcoholized red wine decreased
systolic and diastolic blood pressure, which were correlated with increases in plasma NO. Red wine
prevented fat microparticle sedimentation after a high-fat meal consumption, which could lead to
endothelial dysfunction and cardiovascular events. This effect was also shown by Bulut et al. [84].
Ten healthy males consumed French fries and pork sausages, both high in fat, once a week for four
weeks. They had mineral water, Coke, red wine, and liquor as beverages. It was discovered that a
single, high-fat meal deteriorates endothelial function, which was associated with a significant increase
in circulating microparticles. These negative effects were decreased with red wine.
Oxidative stress plays an important role in arteriosclerosis development. Toth et al. [85] studied
hemorheological parameters in over 1000 patients diagnosed with various forms of ischemic heart
disease during the past decades. In their in vitro and in vivo study, they investigated the effects of
red wine on hemorheological parameters, which play a critical role in the pathogenesis of myocardial
ischemia. The results showed that moderate red wine consumption has beneficial effects on these
parameters, which may explain the French paradox.
Dillenburg et al. [86] evaluated changes in cardiovascular parameters following resveratrol and
polyphenol intake in male Wistar rats. The results indicated the beneficial effects of resveratrol and
grape juice on endothelial nitric oxide synthase, as well as a decrease of vagal modulation and an
increase of the alpha index in the resveratrol group. Resveratrol influenced not only cardiac, but
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also vascular, autonomic modulation. Both resveratrol and grape juice showed beneficial effects,
lowering the risk of possible heart damage during hypertension and eliminating hypertension.
Levantesi et al. [87] evaluated the association of wine intake with an incidence of cardiovascular
events and total mortality after myocardial infarction. The participants included 11,248 Italian patients
who had a recent myocardial infarction, and wine consumption was divided into three groups:
Never/almost never, up to 0.5 L per day, and over this amount. Moderate wine intake was associated
with a reduced risk of cardiovascular events as compared to abstainers. The risk of total mortality
was lower in patients with regular wine intake, but only up to a daily wine consumption of 0.5 L.
The overall results showed that moderate wine consumption in patients with established heart disease
led to a decrease in other cardiovascular events.
The protective properties of red wine in relation to chronic diseases are summarized in Table 6.
Table 6. Summary of the protective effects of red wine in relation to chronic diseases.
Effect Mechanism of Action Study Model Refs.
Anti-inflammatory
Prevented aortic lipid deposition, inhibited
phosphorylation activation, nuclear
translocation, mitochondrial destabilization,
prevented the formation of oxygen free
radicals, increased antioxidant activity
Hamsters,
human cells,
humans
[21,26,38,54,67]
Inhibition of nitric oxide production,
progression of the malignant phase of
intestinal cancer
Rats [69,75]
Antidiabetic
Prevention of diabetes
In vivo and
in vitro models,
humans
[10,18,47]
Enhanced utilization of glucose and
controlled the level of oxidative stress
under diabetic conditions
Rats [26,30]
Decreased the glucose level Rats [15,80]
Cardioprotective
Reduced the risk of cardiovascular diseases Humans, swine,rats [6,44]
Decreased the oxidative stress
Human cells,
humans, rats,
hamsters
[79,83–87]
Hypertension, hypertrophy, coronary artery
disease, and arteriosclerosis Humans [21,22,31,43]
6. Conclusions
After studying the recent available clinical trials, it is evident that not only healthy food, but also
moderate consumption of wine, has a link to cancer prevention. Biological mechanisms for oncological
prevention are associated with the consumption of antioxidants and polyphenols that are contained in
fruits, their products, such as wine, and vegetables. A moderate consumption of wine is recommended
daily, mainly with food [56].
Epidemiological studies have shown that five to seven portions of fresh fruit and vegetables and
two glasses of wine a day can lead to a longer and healthier life [87]. The beneficial effect of wine
is attributed mainly to its antioxidant properties of the large number and amount of polyphenolic
compounds present in red wine [88].
It is recommended that a moderate, optional, daily alcohol consumption is about 15 and 30 g of
alcohol for women and men, respectively. The highest tolerated dose ranges up to 36 g per day for
healthy women and up to 60 g per day for healthy men.
Wine polyphenols could be effective in preventing cardiovascular diseases (CVD). Clinical studies
show that CVD can be influenced by moderate wine consumption. These theses are supported by
many scientists and by scientific tests and clinical studies, but some dismiss the beneficial effects
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of resveratrol. According to the above-mentioned studies, it is possible to strengthen the effect of
resveratrol through a well-balanced diet, such as a form of the “Mediterranean diet”, that includes
red wine, fish, fruits, and vegetables, and foods high in dietary fibre, vitamins, and minerals in the
diet. According to the research, it can be assumed that the substances contained in red wine and
their joint action, when they complement each other, produce the desired effect, namely protection
against cardiovascular diseases. One mechanism of action for resveratrol is reducing damage to
the cardiovascular system due to oxidative stress by neutralizing free oxygen radicals and reactive
nitrogenous radicals. Compared with other antioxidants, resveratrol can penetrate the brain-brain
barrier and, thus, protect the brain and nerve cells. Resveratrol also reduces platelet aggregation and,
thus, counteracts the formation of blood clots or thrombi. The positive effects of wine consumption may
fluctuate depending on the individual substances, especially due to their absorption, the perception of
biologically active substances, and other factors. Thus, this topic requires further careful research.
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